With their unique structural features and significant diverse bioactivities [1] , pregnane glycosides have attracted our attention. Immunosuppressive [2] , anti-inflammatory [3] , anti-epileptic [4] , neuroprotective [5] , anti-hyperglycemic [6] , and cytotoxic [7] activities have been reported for pregnane glycosides, which show great potential as leads in medicine. Epigynum cochinchinensis (Pierre) D.J. Middleton (family Apocynaceae, subfamily Apocynoideae) is generally distributed in forest margins of Thailand, Vietnam, Burma, Laos, and Cambodia [8] . In our preliminary tests, the leaves of this species were rich in pregnane glycosides. As such compounds are rarely reported in the literature, a systemic phytochemical investigation was considered to be very important. In our ongoing search for novel and biologically active pregnane glycosides, a further investigation of the chemical constituents of the EtOAc-soluble fraction from the leaves of E. cochinchinensis was carried out. As a result, one new pregnane glycoside, epigycoside C (1) was isolated (Figure 1 ), together with two known analogues (2-3). The new compound was elucidated by means of spectroscopic methods. The known compounds were confirmed as epigycoside A (2) [9] and epigynoside G (3) [2] by comparison with reported data. Herein, we report the isolation, structure elucidation, and in vitro immunosuppressive activity of epigycoside C (1) by CCK-8 assay.
The leaves of E. cochinchinensis were extracted with methanol and the solvent was removed in vacuo. The crude extract was exhaustively partitioned between water and EtOAc. The EtOAc fraction was purified by conventional chromatographic techniques to yield a new pregnane glycoside, epigycoside C (1), and two known compounds, epigycoside A (2) and epigynoside G (3). The structure of compound 1 was established from extensive spectroscopic data (MS, IR, and 1D and 2D NMR) analysis, whereas the known compounds were confirmed by comparison with NMR data in the literature.
Compound 1 was isolated as a white amorphous powder, and its molecular formula was deduced as C 34 All the isolated compounds were tested for their in vitro cytotoxicity against SMMC-7721, MCF-7, HL-60, SW480, and A-549 human cancer cell lines. None of them showed cytotoxic activity (IC 50 > 10 μM). In our previous work, we reported the immunosuppressive activity of compounds 2 [9] and 3 [2] . Thus, the immunosuppressive activity of new compound 1 was evaluated on mitogen-stimulated mice splenocyte proliferation with dexamethasone as a positive control. Compound 1 significantly inhibited Con A-/LPS-stimulated mice splenocyte proliferation in a dose-dependent manner, which was close to the efficacy of dexamethasone at a concentration of 50 μM (Figures 3 and 4) . However, at a concentration of 12.5 μM, compound 1 showed no significant difference in inhibitory effect on mitogen-stimulated splenocyte proliferation. Acid hydrolysis: Acid hydrolysis of the sample and determination of the absolute configuration of the sugars was performed according to the literature [10] , with a few modifications. Compounds 1-2 (each 3 mg) were dissolved in 1.5 N HCl (2 mL) and heated at 70 °C for 5 h. The reaction mixture was extracted with CHCl 3 (3 × 3 mL). The aqueous layer was neutralized by treatment with NaOH (1 M). Then, a Sephadex LH-20 column was used to isolate the sugars from the aqueous layer by eluting with CH 3 OH. Using CHCl 3 /CH 3 OH/H 2 O/AcOH (40:10:1.0:0.5), the retardation factor (R f ) value was found as 0.6 for 2-O-methyl-6-deoxy-β-Didopyranose and 0.4 for olivopyranose. The aqueous layer was evaporated to dryness for GC analysis. The residue was dissolved in 1 mL anhydrous pyridine, treated with L-cysteine methyl ester hydrochloride (1.5 mg) and stirred at 60 °C for 1 h. Trimethylsilylimidazole (1.5 mL) was added to the reaction mixtures, which were kept at 60 °C for 30 min. The absolute configurations of the sugars were determined by comparing the retention times with those of authentic samples. Thus, the two sugar derivatives of compounds 1-2 had the same retention times as β-Dolivopyranose (21 min) and 2-O-methyl-6-deoxy-β-D-idopyranose (17.5 min). Cytotoxicity assay: The cytotoxicity of compounds 1-3 against 5 human cancer cell lines, MCF-7 (breast cancer), SMMC-7721 (hepatocellular carcinoma), HL-60 (myeloid leukemia), A-549 (lung cancer), and SW480 (colon cancer), was tested using the conventional MTT method [11] . Each cell line was exposed to each test compound at various concentrations in triplicate for 24 h, with cisplatin as the positive control.
Splenocyte proliferation assay:
The spleens of mice were collected and splenocytes were prepared as previously reported [12] . Splencoytes isolated from male BALb/c mice were diluted to a density of 1×10 6 cell/mL and maintained in RPMI 1640 medium supplemented with 100 μg/mL of streptomycin, 100 U/mL of penicillin, and 10% fetal calf serum. Splenocytes were exposed to the test compound at concentrations of 12.5, 25.0, and 50 μM in the presence of concanavalin A (Con A, 10 μg/mL) and lipopolysaccharides (LPS) (10 μg/mL), respectively, using the Con A-/LPStreated splenocytes as the experimental control, dexamethasone (DXM) as positive control and splenocytes without Con A-/LPStreatment as negative control. The tests were conducted for 3 independent replicates and the viability of cells was evaluated using the CCK-8 assay.
Splenocytes after grouping were incubated for 44 h at 37°C in a humidified atmosphere with 5% CO 2 . Sequentially, 10 μL of CCK-8 was added and incubated for another 4 h. Then, the absorbance was detected at 450 nm on a Spectra Max M5 microplate reader (Molecular Devices, Sunnyvale, CA, USA). Data were calculated as the mean of 3 individual experiments. The stimulation index (SI) was calculated based on the following formula: SI = the absorbance value for mitogen-cultures/ the absorbance value for non-stimulated cultures.
Statistical analysis: All statistical tests were performed with the statistical program SPSS 16.0. The data were expressed as mean ± SD. Statistical significance was set at p < 0.05. All analyses were performed using Origin 8.5 software (OriginLab, Northampton, MA, USA).
